May 2026

Featured Evening Symposium
May 17 @ 8:00 am – 8:30 am EDT

Illuminating Pathways in Epithelial-Driven Inflammation: Evolving Management of Upper and Lower Airway Diseases

Learn More

Innovation Hubs
May 17 @ 11:05 am – 11:35 am EDT

An adaptive clinical study programme with IKT-001 for Pulmonary Arterial Hypertension

Innovation Theaters
May 17 @ 11:30 am – 12:30 pm EDT

Clinical Evidence in Severe Asthma: A New Biologic Option for Patients with an Eosinophilic Phenotype

Innovation Theaters
May 17 @ 11:30 am – 12:30 pm EDT

An Overview of JASCAYD¬Æ (nerandomilast) tablets for the Clinician

Innovation Hubs
May 17 @ 11:35 am – 11:55 am EDT

Chronic cough neuropathic mechanisms and treatment opportunities

Innovation Theaters
May 17 @ 11:45 am – 12:30 pm EDT

Taking Control: The Urgent Need to Identify and Address Uncontrolled Asthma

Innovation Hubs
May 17 @ 11:55 am – 12:15 pm EDT

Tuning into Cough in Respiratory Diseases: How Do We Address the Gap?

Featured Innovation Theaters
May 17 @ 12:00 pm – 12:30 pm EDT

Reconsidering the Diagnosis: Could it be CF?

Learn More

Innovation Hubs
May 17 @ 12:15 pm – 12:35 pm EDT

One Scan, Two Functions: Bringing Non-Contrast Ventilation‚ÄìPerfusion Mapping into Everyday CT Practice

Innovation Theaters
May 17 @ 12:30 pm – 1:00 pm EDT

An In-Depth Discussion of Biologic Clinical Trial Data in COPD

Innovation Hubs
May 17 @ 12:35 pm – 12:55 pm EDT

ESI with Spirometry

Innovation Hubs
May 17 @ 12:55 pm – 1:15 pm EDT

Empowering Discovery with Standardized In Vitro Lung Models

Featured Innovation Theaters
May 17 @ 1:00 pm – 1:45 pm EDT

Beyond the Airway: Conversations That Shape Severe Asthma Treatment Decisions

Learn More

Innovation Theaters
May 17 @ 1:00 pm – 2:00 pm EDT

Advancements in Alpha-1 Antitrypsin Deficiency (AATD): Aiming for AAT Restoration and ‚Äã Clinically Meaningful Endpoints‚Äã

Innovation Hubs
May 17 @ 1:15 pm – 1:35 pm EDT

FeNO in Practice: Current Applications and Emerging Opportunities

Featured Innovation Theaters
May 17 @ 1:15 pm – 2:00 pm EDT

The Duality of IL-33 in COPD: Inflammation and Mucus Dysfunction with Dr Monica Kraft, MD

Learn More

Innovation Theaters
May 17 @ 1:30 pm – 2:15 pm EDT

Evidence Expedition: An Interactive Journey Through Clinical Data For AIRSUPRA¬Æ (albuterol 90 mcg/budesonide 80 mcg)

Featured Evening Symposium
May 17 @ 6:30 pm – 7:45 pm EDT

Turning Down the Inflammatory Signal in COPD: Advancing Care With Biologic Therapies Targeting Upstream Cytokines

Learn More

Featured Evening Symposium
May 17 @ 6:30 pm – 8:00 pm EDT

Look Beyond COPD & Severe Asthma: The Role of AAT Protein in Lung Health

Learn More

Featured Evening Symposium
May 17 @ 6:30 pm – 8:30 pm EDT

Gaining Control of Eosinophilic Disorders: Best Practices for Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis

Learn More

Evening Symposium
May 17 @ 6:30 pm – 9:30 pm EDT

Feuding With Fibrosing ILD: Pathways to Timely Diagnosis and Care

Evening Symposium
May 17 @ 7:00 pm – 9:30 pm EDT

Bridging Lived and Clinical Experiences: Patient and Pulmonologist Perspectives in IPF and PPF

Innovation Hubs
May 18 @ 11:05 am – 11:35 am EDT

Raising the Bar with SURPASS-IPF: The First Phase 3 Head-to-Head Superiority Trial in IPF Testing Deupirfenidone vs. Pirfenidone

Innovation Theaters
May 18 @ 11:30 am – 12:30 pm EDT

Problem- Based Learning: Type 2 Inflammation in COPD

Innovation Theaters
May 18 @ 11:30 am – 12:30 pm EDT

Starting at the Top: A Different Approach to Severe Asthma and CRSwNP

Innovation Theaters
May 18 @ 11:45 am – 12:30 pm EDT

YUTREPIA¬Æ (treprostinil) inhalation powder: a prostacyclin treatment for your PH-ILD patients

Innovation Hubs
May 18 @ 11:55 am – 12:15 pm EDT

From Insight to Intervention: Future Clinical Pathways Enabled by CT‚ÄëBased Non-Contrast Ventilation‚ÄìPerfusion Pulmonary Mapping

Innovation Theaters
May 18 @ 12:00 pm – 12:30 pm EDT

XTMAB-16 in Sarcoidosis: First-in-Patient Study Results

Innovation Hubs
May 18 @ 12:15 pm – 12:35 pm EDT

Not All Oxygen Is Delivered Equally: Pulse vs Continuous Flow in Practice and Physiology

Innovation Theaters
May 18 @ 12:30 pm – 1:00 pm EDT

Why Wait to Escalate? New Real-World Evidence Supporting the Use of Triple Therapy in Asthma

Innovation Hubs
May 18 @ 12:35 pm – 12:55 pm EDT

Behind the Science: Ultra Long-Acting Approach to Severe Asthma ‚Äî Two Year Evidence

Innovation Hubs
May 18 @ 12:55 pm – 1:15 pm EDT

Breaking the Cycle: Novel Airway Clearance Technologies and Their Role in Modern Bronchiectasis Care

Innovation Theaters
May 18 @ 1:00 pm – 1:30 pm EDT

Pulmonologist & Cardiologist Live: A Collaborative Approach to Cardiopulmonary Risk in COPD

Innovation Theaters
May 18 @ 1:00 pm – 1:45 pm EDT

A Fresh Perspective on Inflammatory Diseases: Connecting Epithelial Cytokines in Severe Asthma, CRSwNP, and COPD

Innovation Theaters
May 18 @ 1:00 pm – 2:00 pm EDT

Advances in Autoimmune Pulmonary Alveolar Proteinosis: From Pathophysiology to Patient Experience

Innovation Theaters
May 18 @ 1:00 pm – 2:00 pm EDT

The Missing Piece in Asthma Management: Recognizing Small Airway Disease

Innovation Hubs
May 18 @ 1:15 pm – 1:35 pm EDT

CyPath¬Æ Lung Testing in Practice

Innovation Theaters
May 18 @ 1:15 pm – 2:00 pm EDT

Unmet Needs in IPF Understanding Disease Burden and Current Approaches

Innovation Theaters
May 18 @ 1:30 pm – 2:00 pm EDT

Why Wait to Escalate? New Real-World Evidence Supporting the Use of Triple Therapy in Asthma

Innovation Hubs
May 18 @ 1:35 pm – 1:55 pm EDT

Evolving Endpoints in Respiratory Trials Moving Beyond FEV1

Featured Evening Symposium
May 18 @ 6:30 pm – 8:00 pm EDT

Transforming Care in Bronchiectasis: From Myths to Modern Management

Learn More

Featured Evening Symposium
May 18 @ 6:30 pm – 8:30 pm EDT

IL-33 in the Spotlight: Exploring New Pathways for COPD and Acute Respiratory Infections

Learn More

Evening Symposium
May 18 @ 6:30 pm – 9:30 pm EDT

Updates in Refractory Chronic Cough: From Diagnosis and Disease Burden to Underlying Pathophysiology and Emerging Treatments

Evening Symposium
May 18 @ 6:30 pm – 9:30 pm EDT

Treatable Traits, Tailored Care: Targeting Type 2 Inflammation, Enhancing Diagnostic Accuracy, and Promoting Patient Collaboration in COPD Management

Evening Symposium
May 18 @ 6:30 pm – 9:30 pm EDT

Treatment Spotlight for Adult PAH Patients: Clinical Evidence and Insights

Innovation Theaters
May 19 @ 11:30 am – 12:15 pm EDT

A Collaborative Look at Clinical Outcomes of Biologic Use in Asthma and COPD

Featured Innovation Theaters
May 19 @ 11:30 am – 12:30 pm EDT

Bronchiectasis Care With BRINSUPRI: The First Approval in NCFB

Learn More

Innovation Theaters
May 19 @ 11:30 am – 12:30 pm EDT

Are Your Patients at Greater Risk of COPD Exacerbations? It Is Time to Rethink Management for COPD With an Eosinophilic Phenotype

Innovation Hubs
May 19 @ 11:35 am – 11:55 am EDT

Advancing ILD Care: Real-World Impact of Brainomix e-Lung

Innovation Theaters
May 19 @ 11:45 am – 12:30 pm EDT

Filters

Event Category: Open filter Close filter

Cost ($): Open filter Close filter

Day: Open filter Close filter

Time: Open filter Close filter

Featured Events: Open filter Close filter

Date From: Open filter Close filter

Date To: Open filter Close filter

Event Status: Open filter Close filter

Virtual Events: Open filter Close filter

May 2026